ES2170055T3 - Proteinas de mycobacterium y su aplicacion. - Google Patents

Proteinas de mycobacterium y su aplicacion.

Info

Publication number
ES2170055T3
ES2170055T3 ES92911693T ES92911693T ES2170055T3 ES 2170055 T3 ES2170055 T3 ES 2170055T3 ES 92911693 T ES92911693 T ES 92911693T ES 92911693 T ES92911693 T ES 92911693T ES 2170055 T3 ES2170055 T3 ES 2170055T3
Authority
ES
Spain
Prior art keywords
proteins
application
mycobacterium
mycobacterium proteins
around
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92911693T
Other languages
English (en)
Inventor
Gilles Marchal
Felix Romain
Pascale Pescher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur
Original Assignee
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur filed Critical Institut Pasteur
Application granted granted Critical
Publication of ES2170055T3 publication Critical patent/ES2170055T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Gram-positive bacteria
    • C07K16/1289—Mycobacteriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

PROTEINAS DE MYCOBACTERIUM, Y EN PARTICULAR DE M. BOUIS QUE PRESENTAN UN PESO MOLECULAR COMPRENDIDO ENTRE 44,5 Y 47,5 KD APROXIMADAMENTE. ESTAS PROTEINAS PUEDEN POSEER UNOS PESOS MOLECULARES DE ALREDEDOR DE 45 KD O 47 KD Y UNOS PH ISOELECTRICOS DE ALREDEDOR DE 3,7 (PROTEINAS 45 Y 47 KD) Y DE 3,9 (PROTEINAS DE 47 KD). ESTAS PROTEINAS O UNAS PROTEINAS HIBRIDAS QUE COMPRENDEN UNA PARTE DE SUS SECUENCIAS PUEDEN SER UTILIZADAS COMO VACUNAS O COMO MEDICAMENTOS, O PARA LA DETECCION Y EL SEGUIMIENTO DE LA TUBERCULOSIS EN PARTICULAR ENTRE LOS HOMBRES Y LOS BOVINOS.
ES92911693T 1991-06-07 1992-06-05 Proteinas de mycobacterium y su aplicacion. Expired - Lifetime ES2170055T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9106970A FR2677365B1 (fr) 1991-06-07 1991-06-07 Proteines de mycobacterium et applications.

Publications (1)

Publication Number Publication Date
ES2170055T3 true ES2170055T3 (es) 2002-08-01

Family

ID=9413612

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92911693T Expired - Lifetime ES2170055T3 (es) 1991-06-07 1992-06-05 Proteinas de mycobacterium y su aplicacion.

Country Status (10)

Country Link
US (2) US5962240A (es)
EP (1) EP0589943B1 (es)
JP (1) JPH06508513A (es)
AT (1) ATE214399T1 (es)
CA (1) CA2110389A1 (es)
DE (1) DE69232483T2 (es)
DK (1) DK0589943T3 (es)
ES (1) ES2170055T3 (es)
FR (1) FR2677365B1 (es)
WO (1) WO1992021758A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2677365B1 (fr) * 1991-06-07 1995-08-04 Pasteur Institut Proteines de mycobacterium et applications.
US5330754A (en) * 1992-06-29 1994-07-19 Archana Kapoor Membrane-associated immunogens of mycobacteria
JPH09505588A (ja) 1993-11-23 1997-06-03 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 多くの細胞外生成物及びそれらの製造法並びに使用
US6752993B1 (en) 1993-11-23 2004-06-22 The Regents Of The University Of California Abundant extracellular product vaccines and methods for their production and use
WO1996005223A1 (en) * 1994-08-12 1996-02-22 The Regents Of The University Of California Abundant extracellular products and methods for their production and use
US5714593A (en) * 1995-02-01 1998-02-03 Institut Pasteur DNA from mycobacterium tuberculosis which codes for a 45/47 kilodalton protein
US6592877B1 (en) 1995-09-01 2003-07-15 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
AU727602B2 (en) * 1995-09-01 2000-12-14 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6338852B1 (en) 1995-09-01 2002-01-15 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
CA2230927A1 (en) * 1995-09-01 1997-03-13 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
EP1712629A3 (en) * 1995-09-01 2009-09-09 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
US6290969B1 (en) 1995-09-01 2001-09-18 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6458366B1 (en) 1995-09-01 2002-10-01 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
BR9712298A (pt) * 1996-10-11 2000-10-24 Corixa Corp Polipeptìdeo, molécula de dna, vetor de expressão recombinante, célula hospedeira, processo para detectar infecção por m. tuberculosis em uma amostra biológica, kit diagnóstico, anticorpos monoclonal, e, policlonal, e, proteìna de fusão
US6465633B1 (en) 1998-12-24 2002-10-15 Corixa Corporation Compositions and methods of their use in the treatment, prevention and diagnosis of tuberculosis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ228529A (en) * 1988-03-31 1991-07-26 Commw Scient Ind Res Org Diagnosis of mycobacterium bovis infection in a susceptible animal
FR2677365B1 (fr) * 1991-06-07 1995-08-04 Pasteur Institut Proteines de mycobacterium et applications.
FR2688785B1 (fr) * 1992-03-19 1995-07-07 Pasteur Institut Sequence peptidique apte a induire une reaction d'hypersensibilite de type retarde en presence de bacteries vivantes du complexe mycobacterium tuberculosis, et ses applications.

Also Published As

Publication number Publication date
WO1992021758A1 (fr) 1992-12-10
JPH06508513A (ja) 1994-09-29
DE69232483T2 (de) 2002-11-21
EP0589943B1 (fr) 2002-03-13
FR2677365B1 (fr) 1995-08-04
DE69232483D1 (de) 2002-04-18
US6060259A (en) 2000-05-09
CA2110389A1 (fr) 1992-12-10
FR2677365A1 (fr) 1992-12-11
EP0589943A1 (fr) 1994-04-06
ATE214399T1 (de) 2002-03-15
US5962240A (en) 1999-10-05
DK0589943T3 (da) 2002-07-01

Similar Documents

Publication Publication Date Title
ES2170055T3 (es) Proteinas de mycobacterium y su aplicacion.
DK0807178T3 (da) Mycobaktielle proteiner, mikroorganismer producerende samme og anvendelser af nævnte proteiner i vacciner og til påvisning af tuberkulose
ES2090725T3 (es) Colchon superior para un sistema de colchones.
NO308065B1 (no) Faste lyofiliserte doseringsformer
DK183386A (da) Sucralfatsuspension
ES2093122T3 (es) Activacion mejorada de proteinas recombinantes.
ES2056817T3 (es) Transformacion de trichoderma.
ES2169102T3 (es) (r)-(-)-2-(5-(4-fluorfenil)-3-piridilmetilaminometil)-cromano como agente activo sobre el sistema nervioso central.
DE68917323D1 (de) Expressions-Vektor für Fusions-Proteine und Immunogen-Proteine.
NO962560L (no) Materialer og metoder ved påvisning av stpahylococcus aureus
IT1228370B (it) Dispositivo emulsionatore dotato di uno o piu' organi rotanti che vengono messi in movimento da vapore pressurizzato, particolarmente indicato per la preparazione di cappuccini e simili.
DE3689150D1 (de) Druckablass-, quell- und trocknungsvorrichtung.
DE69312659D1 (de) Nagellackentferner mit Gelatine
EA199900362A1 (ru) Новые соединения, полезные для использования в качестве нейрозащитных средств
DE69419966D1 (de) Impstoff gegen Streptococcus suis-Infektion
FI844129A0 (fi) Kompositioner baserade pao eldfast polyamid.
NO924670L (no) Derivater av 6-aminooktahydroindolizintriol
ES524439A0 (es) Procedimiento de obtencion de los 2-amino 5- (aralcoil piperidino alcoil) amino 1,4-diazoles
ES2108809T3 (es) Mezclas solidas de estabilizadores para polimeros.
ES2181787T3 (es) Derivados de la 3h-2,3-benzodiazepina sustituidos en posicion 3, y su su utilizacion como medicamentos
ES8607111A1 (es) Perfeccionamientos en los aparatos de dimensionar elementos de acoplamiento para cierres de cremallera
SE8803183L (sv) Manoevreringssystem
SE8902186L (sv) Nya polypeptider och deras anvaendning
ES2072869T3 (es) Uso de derivados de la 1,4-dihidropiridina en el tratamiento del alcoholismo.
NO154416C (no) Haarfargemiddel.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 589943

Country of ref document: ES